Navigation Links
Regal One Announces Dividend of Rampart Detection Systems Common Stock
Date:5/31/2011

SCOTTSDALE, Ariz., May 31, 2011 /PRNewswire/ -- Regal One Corporation (OTCBB:RONE), an emerging business development corporation that is 100% focused on incubating and bringing public high quality companies, today announced it will distribute a special dividend of 300,000 shares of Rampart Detection Systems Ltd Common stock. Regal One is assisting in the filing of an F-1 registration statement with the United States Securities and Exchange Commission, wherein these shares may be registered in whole or in part for public resale. Based in Western Canada, Rampart is a world leader in applying the most advanced knowledge of electromagnetics and electrodynamics to detection and protection systems for police; defense; security; counter terrorism; emergency response and industry.

Regal shareholders of record June 10, 2011, will receive as a dividend, on pro rata basis, a total of 300,000 Rampart common shares. Rampart expects to file an F-1 registration statement on or about June 3, 2011. The dividend will be distributed to Regal shareholders after the registration statement is declared effective.

Since 2005 Regal One has been operating as a Business Development Corporation 100% focused on recruiting, coaching, and bringing public next-generation companies. Regal seeks high tech industrial and biomedical companies with well defined near-term applications that address significant and quantifiable markets. Based in Scottsdale, AZ, the company provides qualified candidates access to the best-of-breed advisors, and the shortest, least expensive path to public liquidity.

FORWARD-LOOKING STATEMENTS

This press release contains forward-looking statements. Matters discussed in this press release contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. When used in this press release, the words "anticipate," "believe," "estimate," "may," "intend," "expects" and similar expressions identify such forward-looking statements. Although expected, actual results, performance or achievements could differ materially from those contemplated, expressed or implied by the forward-looking statements contained herein. These forward-looking statements are based largely on the expectations of Regal One Corporation and are subject to a number of risks and uncertainties. These include, but are not limited to, risks and uncertainties associated with: the impact of economic, competitive and other factors affecting Regal One and its operations; its markets, products, and portfolio performance, and other factors detailed in reports filed by Regal One with the SEC.


'/>"/>
SOURCE Regal One Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Regal Introduces Four, Six and Eight Port Filtered and Un-Filtered Right Angle BNC Connectors
2. China-Biotics, Inc. Announces Conference Call to Discuss First Quarter 2009 Financial Results
3. Odyssey Thera Announces Milestone Achievement in Pfizer Alliance
4. InNexus Biotechnology Announces Launch of Large Scale Primate Study of DXL625
5. Anesiva Announces Second Quarter 2008 Financial Results and Update
6. SGX Pharmaceuticals Announces Financial Results for the Three and Six Months Ended June 30, 2008
7. Insmed Announces Financial Results for Second Quarter and Six-Months Ended June 30, 2008
8. China Sky One Medical, Inc. Announces Conference Call to Discuss Second Quarter 2008 Results
9. China Yingxia International, Inc. Announces Conference Call to Discuss Second Quarter 2008 Results
10. ThirdBiotech Announces Kemeta as Newest Sponsor
11. Signalife Announces Intent to Withdraw From AMEX and Trade on the OTCBB
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... ... October 11, 2017 , ... The CRISPR-Cas9 system ... experiments and avoiding the use of exogenous expression plasmids. The simplicity of programming ... systematic gain-of-function studies. , This complement to loss-of-function studies, such as with ...
(Date:10/11/2017)... HILLS, Calif. , Oct. 11, 2017  SkylineDx today ... (ICR) and University of Leeds ... risk-stratify patients with multiple myeloma (MM), in a multi-centric Phase ... University of Leeds is the sponsor ... and ICR will perform the testing services to include high-risk ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... conjugate (ADC) therapeutics, today confirmed licensing rights that give it exclusive global ... technology developed in collaboration with Children’s Hospital Los Angeles (CHLA). Additionally, ...
(Date:10/10/2017)... ... 10, 2017 , ... USDM Life Sciences , the ... sciences and healthcare industries, announces a presentation by Subbu Viswanathan and Jennifer Jaye ... GxP Validation for Agile Cloud Platforms,” will present a revolutionary approach to achieving ...
Breaking Biology Technology:
(Date:8/15/2017)... Va. , Aug. 15 2017   ivWatch LLC , ... of intravenous (IV) therapy, today announced receipt of its ISO 13485 ... developed by the International Organization for Standardization (ISO®). ... ivWatch Model 400 Continuous Monitoring device for the ... "This is ...
(Date:5/23/2017)... first robotic gym for the rehabilitation and functional motor sense evaluation of ... Italy . The first 30 robots will be available from June ... . The technology was developed and patented at the IIT laboratories and ... thanks to a 10 million euro investment from entrepreneur Sergio Dompè. ... ...
(Date:4/19/2017)... New York , April 19, 2017 ... competitive, as its vendor landscape is marked by the ... the market is however held by five major players ... Safran. Together these companies accounted for nearly 61% of ... of the leading companies in the global military biometrics ...
Breaking Biology News(10 mins):